HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Nonprofit Pharmaceutical Companies

543.943

+20.4983.92%

Number of Gainers:19

Number of Losers:10

Number of Flat:4

PE:- -

High:544.615

Open:523.445

Low:521.250

Close:523.445

Volume:128.67M

Turnover:4.35B

Market Cap:347.66B

Float Cap:309.50B

Loading ...

Ascentage Pharma Reports 2026 Interim Results: Strengthening Commercial Engine and Accelerating Global Expansion

Ascentage Pharma Group International Posts H1 Net Loss Attributable Rmb816.7 Million

China's Ascentage Pharma H1 Revenue Rises 29% on Lisaftoclax Ramp-up

Ascentage Pharma Group International H1 Revenue RMB 302.2 Million

THOMSON REUTERS

Ascentage Pharma FY26 H1 Loss Widens to Us$120.4 Million; Revenue Rises 29% to Us$44.5 Million

Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates

THOMSON REUTERS

Evening Market Wrap: Cancer Vaccine Breakthrough Sends US Pharma Soaring, SK Hynix Announces Massive Buyback

Kintor Pharma-B Reports Interim Results with Narrowed Net Loss of RMB 75.6 Million

Kintor Net Loss Narrows 9% to RMB 75.8 Million in 1H FY26; Revenue Rises to RMB 52 Million

Kintor Pharmaceutical H1 Revenue RMB 52 Million

THOMSON REUTERS

Global First mRNA Cancer Vaccine Hits Major Milestone, 3D Medicines Jumps 17% on International Revaluation

Akeso (SEHK:9926) Could Be 47% Undervalued As China Approves Ivonescimab Use

Simply Wall St.

KEYMED BIO-B (02162) Announces Proposed RMB Share Issuance for STAR Market Listing

Keymed Biosciences Plans RMB Share Listing on Shanghai STAR Market

KeyMed Biosciences - no Application Made to Regulatory Authorities for RMB Share Issue as of Aug 19, 2026

THOMSON REUTERS

KeyMed Biosciences - Proposes RMB Share Issue for Sci-Tech Board Listing

THOMSON REUTERS

KeyMed Biosciences H1 Revenue RMB 617.068 Million

THOMSON REUTERS

US Treasury Turmoil Batters Tech Stocks While Banks Steady Hong Kong Market

CARsgen Therapeutics (SEHK:2171) Stock Carries Premium Valuation Despite Ongoing Losses

Simply Wall St.

Zylox-Tonbridge Files HKEX Next-Day Disclosure Return, Lifts Share Capital by 250,000 Shares

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/BK1574/news?page=12"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":543.9429,"timestamp":1787818109125,"preClose":523.44507,"halted":0,"volume":128668048,"delay":0,"changeRate":0.039159,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":20.497803,"latestTime":"08-27 16:00:00","open":523.44507,"high":544.61487,"low":521.25024,"amount":4346598714,"amplitude":0.044636,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787880600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1787794200000,1787803200000],[1787806800000,1787817600000]],"pbRate":3.928132,"peRate":157.633502,"turnoverRate":0.004604,"increases":18,"decrements":12,"flats":3,"marketCap":347655044144,"floatMarketCap":309501595848},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":544.61487,"amplitude":0.044636,"preClose":523.44507,"low":521.25024,"pbRate":"3.928132","latestPrice":543.9429,"volume":128668048,"delay":0,"open":523.44507,"prevYearClose":556.26263,"prevWeekClose":506.075,"prevMonthClose":473.313,"prevQuarterClose":453.519,"fiveDayClose":517.015,"twentyDayClose":469.634,"sixtyDayClose":496.38,"secType":"PLATE","market":"HK","turnoverRate":0.004604,"peRate":157.633502,"marketCap":347655044144,"floatMarketCap":309501595848,"timestamp":1787818109125,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":19,"down":10,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:12,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1199487193","title":"Ascentage Pharma Reports 2026 Interim Results: Strengthening Commercial Engine and Accelerating Global Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=1199487193","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199487193?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:40","pubTimestamp":1787182818,"startTime":"0","endTime":"0","summary":"Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855) has announced its interim results for the first half of 2026, showcasing continued momentum in its commercial operations. Total revenue for the period...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06855","BK1574","BK4139","AAPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660116479","title":"Ascentage Pharma Group International Posts H1 Net Loss Attributable Rmb816.7 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660116479","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660116479?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:29","pubTimestamp":1787182190,"startTime":"0","endTime":"0","summary":"BRIEF-Ascentage Pharma Group International Posts H1 Net Loss Attributable RMB816.7 MillionAug 20 (Reuters) - Ascentage Pharma Group International H1 revenue RMB 302.2 millionH1 net income attributable RMB -816.7 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nPLXJC7R3Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06855","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660479671","title":"China's Ascentage Pharma H1 Revenue Rises 29% on Lisaftoclax Ramp-up","url":"https://stock-news.laohu8.com/highlight/detail?id=2660479671","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660479671?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:17","pubTimestamp":1787181459,"startTime":"0","endTime":"0","summary":"China's Ascentage Pharma H1 revenue rises 29% on Lisaftoclax ramp-upOverviewChina oncology drug developer's H1 revenue rose 29% yr/yr on higher product salesNet loss widened as operating expenses and ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nL1N44G15G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","IE00BZ08YT58.USD","LU2148510915.USD","LU1934453819.USD","06855","BK1574","IE00BZ08YS42.EUR","01177","LU0196878994.USD","IE00BZ08YR35.GBP","002422","BK1161","BK1515","HK0000165453.HKD","BK1589","06990","BK1191","LU1064130708.USD","LU1979443071.USD","LU1064131003.USD","BK0239","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660479392","title":"Ascentage Pharma Group International H1 Revenue RMB 302.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660479392","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660479392?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:00","pubTimestamp":1787180455,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nPLXJC7R3Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1161","06855"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660313479","title":"Ascentage Pharma FY26 H1 Loss Widens to Us$120.4 Million; Revenue Rises 29% to Us$44.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660313479","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660313479?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:00","pubTimestamp":1787180428,"startTime":"0","endTime":"0","summary":"Ascentage Pharma FY26 H1 loss widens to US$120.4 million; revenue rises 29% to US$44.5 millionAscentage Pharma revenue rose 29% year over year to US$ 44.5 million for the six months ended June 30, 202","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL6yrd94:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014005.SGD","IE00BKPKM429.USD","BK4588","IE00BQXX3C00.GBP","LU0314104364.USD","LU2095319765.USD","BK4585","IE00BQXX3F31.USD","IE00BQXX3D17.EUR","IE00BN0W2V16.EUR","LU2210150020.SGD","BCDF","NDAQ","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4112","IE00BN0W2W23.USD","SG9999014039.USD","06855","BK1574","SG9999014021.USD","IE00BGHQF748.EUR","BK1161","IE00BN0W2T93.GBP","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660793944","title":"Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2660793944","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660793944?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:00","pubTimestamp":1787180400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nTUA4ML19T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06855","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1170810384","title":"Evening Market Wrap: Cancer Vaccine Breakthrough Sends US Pharma Soaring, SK Hynix Announces Massive Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=1170810384","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1170810384?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:40","pubTimestamp":1787150452,"startTime":"0","endTime":"0","summary":"Here are the key evening market developments investors need to know. NDRC Advances 'Six Networks' Infrastructure Plan On August 19, the National Development and Reform Commission (NDRC) held a...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07233","83188","399300","03130","159982","83130","BK1147","02846","159646","BK1515","BK1574","02827","09939","159938","03188","BK1161","82846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178952366","title":"Kintor Pharma-B Reports Interim Results with Narrowed Net Loss of RMB 75.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1178952366","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178952366?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:40","pubTimestamp":1787150416,"startTime":"0","endTime":"0","summary":"Kintor Pharma-B (09939) has unveiled its interim financial results for the period ending June 30, 2026, showcasing a notable surge in revenue from RMB 6 million in the prior-year period to RMB 52...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1515","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660242429","title":"Kintor Net Loss Narrows 9% to RMB 75.8 Million in 1H FY26; Revenue Rises to RMB 52 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660242429","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660242429?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:33","pubTimestamp":1787149999,"startTime":"0","endTime":"0","summary":"Kintor net loss narrows 9% to RMB 75.8 million in 1H FY26; revenue rises to RMB 52 millionKintor posted revenue of RMB 52 million, up 766.7% year over year, driven by global sales of its KOSHIN cosmet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL7xt97N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1574","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660429211","title":"Kintor Pharmaceutical H1 Revenue RMB 52 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660429211","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660429211?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:32","pubTimestamp":1787149978,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nPLXXDMDQT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","BK1515","09939","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150133670","title":"Global First mRNA Cancer Vaccine Hits Major Milestone, 3D Medicines Jumps 17% on International Revaluation","url":"https://stock-news.laohu8.com/highlight/detail?id=1150133670","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150133670?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:22","pubTimestamp":1787149350,"startTime":"0","endTime":"0","summary":"On August 19, a landmark moment arrived for tumor immunotherapy. Moderna and Merck announced that their phase III clinical trial, INTerpath-001, evaluating the tumor neoantigen mRNA vaccine mRNA-4157...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1574","BK1161","09939","01244","159646","159938"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660244894","title":"Akeso (SEHK:9926) Could Be 47% Undervalued As China Approves Ivonescimab Use","url":"https://stock-news.laohu8.com/highlight/detail?id=2660244894","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660244894?lang=en_us&edition=fundamental","pubTime":"2026-08-19 22:20","pubTimestamp":1787149244,"startTime":"0","endTime":"0","summary":"Akeso (SEHK:9926) is back in focus after China’s National Medical Products Administration approved ivonescimab plus chemotherapy as a first-line treatment for advanced squamous non-small cell lung cancer.\nSee our latest analysis for Akeso.\nDespite the positive ivonescimab news, Akeso’s share price has come under pressure, with the stock down 12.54% over the past week and 21.18% year to date. At the same time, the 3 year total shareholder return of 185.76% and 5 year total shareholder return...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-sehk9926-could-be-47-undervalued-as-china-approves-ivo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9926/akeso-shares/news/akeso-sehk9926-could-be-47-undervalued-as-china-approves-ivo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00B5MMRT66.SGD","LU0348767384.USD","LU0634319403.HKD","LU0348825331.USD","BK1574","LU2488822045.USD","LU0561508036.HKD","LU2476274308.USD","LU0348827113.USD","LU1794554557.SGD","LU0348783233.USD","LU0417516571.SGD","BK1161","LU2399975544.HKD","LU0348784397.USD","LU0417516902.SGD","LU1720050803.USD","LU0348735423.USD","LU1961090484.USD","LU2778985437.USD","LU0348766576.USD","LU0540923850.HKD","IE00BPRC5H50.USD","KURE","09926","IE00B543WZ88.USD","LU0417516738.SGD","LU2476274720.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189925275","title":"KEYMED BIO-B (02162) Announces Proposed RMB Share Issuance for STAR Market Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1189925275","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189925275?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:40","pubTimestamp":1787146814,"startTime":"0","endTime":"0","summary":"KEYMED BIO-B (02162) has announced that its board of directors resolved on August 19, 2026, to propose the issuance of ordinary shares denominated and traded in Renminbi, with a planned listing on...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["UCmain","KSTR","BK1574","MUCmain","CYB","BK1161","02162","BK1587","CNHmain","IPOS","MCNHmain","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660425003","title":"Keymed Biosciences Plans RMB Share Listing on Shanghai STAR Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2660425003","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660425003?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:32","pubTimestamp":1787146323,"startTime":"0","endTime":"0","summary":"Keymed Biosciences plans RMB share listing on Shanghai STAR MarketKeymed Biosciences’ board on Aug. 19, 2026 backed a plan to issue RMB-denominated ordinary shares for listing on Shanghai’s Sci-Tech B","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL75lXNG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1574","02162","BK1587","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660425012","title":"KeyMed Biosciences - no Application Made to Regulatory Authorities for RMB Share Issue as of Aug 19, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2660425012","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660425012?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:31","pubTimestamp":1787146294,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nFWN44G0G8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1161","BK1583","02162","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660250934","title":"KeyMed Biosciences - Proposes RMB Share Issue for Sci-Tech Board Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2660250934","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660250934?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:31","pubTimestamp":1787146294,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nFWN44G0G8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1583","02162","BK1587","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660425459","title":"KeyMed Biosciences H1 Revenue RMB 617.068 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2660425459","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660425459?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:23","pubTimestamp":1787145836,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nPLXHNXCKZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1587","BK1161","BK1574","BK1583","02162"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171659413","title":"US Treasury Turmoil Batters Tech Stocks While Banks Steady Hong Kong Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1171659413","media":"Stock News","labels":["economic"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171659413?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:59","pubTimestamp":1787144382,"startTime":"0","endTime":"0","summary":"Global technology equities faced a brutal selloff that originated on Wall Street, with the Philadelphia Semiconductor Index (SOX) plunging 4.98% overnight as all 30 constituent stocks closed lower,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868837565.USD","BK4504","HK0000320223.HKD","LU0634319403.HKD","LU0708995583.HKD","VMAX","LU0244354667.USD","BOXX","DBND","01907","LU0359202008.SGD","LU1770036033.HKD","SG9999001093.SGD","LU0164865239.USD","LU0359201612.USD","VLUE","BKDV","LU0823426308.USD","LU0210526637.USD","TLTW","SHV","LU1868838027.USD","LU2778985437.USD","NGHT","LU1813983027.USD","LU1993786604.SGD","81810","LU2152927971.USD","LU0164880469.USD","LU2476274720.SGD","LU2488822045.USD","00300","LU2294711473.HKD","LU0588546209.SGD","SGOV","LU0823038988.USD","LU0675040207.SGD","LU0449515922.USD","KCAI","LU0117841782.USD","LU0314109678.HKD","LU1105468828.SGD","TBT","LU2399975544.HKD","BK1589","LU1770034418.SGD","MINT","LU0823041008.USD","LU0499858438.USD","AGG","LU1720050803.USD","LU1880383440.USD","LU0348827113.USD","LU0164872284.USD","BK1610","LU0823397103.USD","LU1481107354.HKD","LU0169518387.USD","HMOP","IGOV","MUNX","BWX","LU0149721374.USD","BK4581","LU0326950275.SGD","LU1188198961.HKD","LU0051755006.USD","PRF","LU0918141705.HKD","JPST","LU0572944931.SGD","BITC","LU0348735423.USD","LU0359201885.HKD","LU2226246903.HKD","GBIL","IE0032431581.USD","LU0211977185.USD","LU2087589342.USD","LU1282648689.USD","LU0441854154.USD","VALQ","BK1618","LU1961090484.USD","LU2097828474.EUR","HK0000165453.HKD","09688","IEF","BNDW","LU0214875030.USD","LU0345776255.USD","BOND","TLTI","LU0231483743.USD","LU0540923850.HKD","BK1607","LU1303224171.USD","LU0823040885.USD","VCIT","LU0456827905.SGD","LU0594300419.USD","LU0307460666.USD","LU0871576103.HKD","XIACY","UFIV","BK1506","BK1141","BK4535","LU0348814723.USD","LU0417516902.SGD","UBT","DFLV","BK4585","LU1719994722.HKD","LU0823039010.USD","LU0449509016.USD","LU0700851271.USD","LU0345775950.USD","UTHY","ZFmain","LU0823397285.USD","LU1251922891.USD","TSYW","ZNmain","TLTX","BK1161","HXXD.SI","LU1880383366.USD","TALV","LU0823426480.USD","LU2097828805.USD","SG9999002463.SGD","LU0235996351.USD","ABEQ","LU0417516738.SGD","BWZ","USVN","CIVG","BK1615","LU0531971595.HKD","GOLY","BK1575","TFJL","TYO","SWP","LU0611395673.USD","TBJL","VGLT","LU1023057109.AUD","LU0456846285.SGD","SHY","VXUS","TIP","XBIL","LU1960683339.HKD","UTWY","LU1323998911.USD","LU0039217434.USD","TNmain","BK1502","LU0143863198.USD","LU0605514214.HKD","01548","BK4550","LU0348816934.USD","BBIB","BSV","LU0320764599.SGD","LU0594300179.USD","LU1808992512.USD","VCSH","LU0499858602.USD","BK1523","HYG","LU2097828557.USD","SCHO","USHY","HK0000306685.HKD","LU1328277881.USD","BBSB","BBLB","BK4588","FLGV","MIUmain","MWNmain","UBmain","LU0254981946.USD","LU0561508036.HKD","LU0650527681.SGD","TBIL","WAMA","VGSH","SPVM","UTRE","ISHG","LU0918141887.USD","LU0348825331.USD","MTNmain","ZTmain","LU0593848301.USD","ROPE","HK0000306701.USD","CGVV","LU0054450605.USD","MYCN","BND","IE0034224299.USD","IE00B0169L03.USD","BK1583","BK1110","BK1193","SG9999003461.SGD","01810","HK0000320264.USD","LU2257852520.SGD","VGIT","ZROZ","LU0531970944.HKD","BIL","BK1214","TLH","IE00B3M56506.USD","BK1588","LU1807302812.USD","VUSV","GOVT","EQRR","LU2097828714.EUR","LU1794554557.SGD","BK4561","LU0823413587.USD","MUB","LU0463099449.HKD","LU2039709279.SGD","HK0000286598.CNH","LU1956131251.USD","ZBmain","IEI","LU1981816686.USD","LU2097828631.EUR","TMF","LU0797268264.HKD","DRGN","LQD","LU0823413660.USD","LU0084288322.USD","BK1574","EDV","LU0052750758.USD","TLT","BK1576","PY","BK1521","VTV","LU2476274308.USD","LU0327786744.USD","LU0143863784.USD","LIAJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660431424","title":"CARsgen Therapeutics (SEHK:2171) Stock Carries Premium Valuation Despite Ongoing Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=2660431424","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660431424?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:27","pubTimestamp":1787142431,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings closed at HK$14.90 today after a choppy few months in which the stock has slipped about 15% over 90 days. Yet behind the weak chart, the latest half year numbers point to one issue that matters most for you as a shareholder. The balance sheet and valuation strain is now the key tension between short term sentiment and long term promise.\nRevenue for the first half of 2026 came in at ¥61.9 million, while the company still reported a net loss of ¥66.7 million. With...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/carsgen-therapeutics-sehk2171-stock-carries-premium-valuatio","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/carsgen-therapeutics-sehk2171-stock-carries-premium-valuatio","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1587","BK4539","BK1161","BK4139","BK1574","BK4007","BK1585","02171","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660702428","title":"Zylox-Tonbridge Files HKEX Next-Day Disclosure Return, Lifts Share Capital by 250,000 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2660702428","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660702428?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:25","pubTimestamp":1787142331,"startTime":"0","endTime":"0","summary":"Zylox-Tonbridge files HKEX next-day disclosure return, lifts share capital by 250,000 sharesZylox-Tonbridge filed a next-day disclosure return covering a transfer of 250,000 H Shares from treasury on ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nNDL5sPjqv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1574","02190","BK1587","BK1100"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":16,"pageCount":12,"totalSize":316,"code":"91000000","status":"200"}]}}